I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| granule cell | 3 studies | 24% ± 4% | |
| glutamatergic neuron | 3 studies | 28% ± 16% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| granule cell | 3 studies | 24% ± 4% | |
| glutamatergic neuron | 3 studies | 28% ± 16% |
Insufficient scRNA-seq data for expression of GALNT9 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 89% | 4178.98 | 2352 / 2642 | 82% | 9.36 | 581 / 705 |
| thymus | 98% | 1546.79 | 643 / 653 | 65% | 4.84 | 396 / 605 |
| kidney | 98% | 631.21 | 87 / 89 | 58% | 4.02 | 526 / 901 |
| adrenal gland | 26% | 84.49 | 67 / 258 | 26% | 2.04 | 59 / 230 |
| intestine | 25% | 69.98 | 237 / 966 | 10% | 0.42 | 53 / 527 |
| ovary | 21% | 68.44 | 37 / 180 | 13% | 1.33 | 56 / 430 |
| adipose | 33% | 419.17 | 398 / 1204 | 0% | 0 | 0 / 0 |
| uterus | 16% | 68.69 | 27 / 170 | 9% | 0.25 | 40 / 459 |
| prostate | 19% | 46.60 | 47 / 245 | 1% | 0.04 | 7 / 502 |
| spleen | 17% | 42.71 | 40 / 241 | 0% | 0 | 0 / 0 |
| stomach | 9% | 27.96 | 34 / 359 | 7% | 0.21 | 19 / 286 |
| lung | 6% | 32.62 | 34 / 578 | 4% | 0.19 | 49 / 1155 |
| bladder | 5% | 20.33 | 1 / 21 | 3% | 0.15 | 15 / 504 |
| heart | 5% | 21.44 | 44 / 861 | 0% | 0 | 0 / 0 |
| pancreas | 0% | 0 | 0 / 328 | 4% | 0.14 | 8 / 178 |
| tonsil | 0% | 0 | 0 / 0 | 4% | 0.08 | 2 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 0.04 | 1 / 29 |
| liver | 0% | 2.10 | 1 / 226 | 2% | 0.06 | 10 / 406 |
| eye | 0% | 0 | 0 / 0 | 3% | 0.07 | 2 / 80 |
| esophagus | 0% | 0.35 | 2 / 1445 | 2% | 0.07 | 4 / 183 |
| blood vessel | 2% | 6.80 | 28 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 1% | 5.27 | 12 / 929 | 0% | 0 | 0 / 0 |
| skin | 0% | 0.11 | 1 / 1809 | 1% | 0.02 | 4 / 472 |
| breast | 0% | 0.37 | 1 / 459 | 0% | 0.02 | 4 / 1118 |
| muscle | 0% | 0.22 | 1 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0016266 | Biological process | O-glycan processing |
| GO_0006493 | Biological process | protein O-linked glycosylation |
| GO_0000139 | Cellular component | Golgi membrane |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_0004653 | Molecular function | polypeptide N-acetylgalactosaminyltransferase activity |
| GO_0030246 | Molecular function | carbohydrate binding |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | GALNT9 |
| Protein name | Polypeptide N-acetylgalactosaminyltransferase 9 (EC 2.4.1.41) (Polypeptide GalNAc transferase 9) (GalNAc-T9) (pp-GaNTase 9) (Protein-UDP acetylgalactosaminyltransferase 9) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 9) Polypeptide N-acetylgalactosaminyltransferase 9 Polypeptide N-acetylgalactosaminyltransferase (EC 2.4.1.-) (Protein-UDP acetylgalactosaminyltransferase) GALNT9 protein |
| Synonyms | |
| Description | FUNCTION: Catalyzes the initial reaction in O-linked oligosaccharide biosynthesis, the transfer of an N-acetyl-D-galactosamine residue to a serine or threonine residue on the protein receptor. Does not glycosylate apomucin or SDC3. . |
| Accessions | ENST00000671997.1 [Q9HCQ5-2] ENST00000328957.13 Q68VJ2 ENST00000538356.1 ENST00000397325.6 [Q9HCQ5-2] F5H317 ENST00000542942.1 ENST00000673376.1 [Q9HCQ5-2] Q9HCQ5 F5H557 J3KNN1 ENST00000411988.6 B2RXG6 ENST00000541995.5 [Q9HCQ5-2] H3BM10 |
